ARTICLE | Distillery Therapeutics
Cancer
July 18, 2017 9:05 PM UTC
Patient sample, in vitro, cell culture and mouse studies identified a benzamide-based CSNK1A activator that could help treat Wnt signaling-driven colorectal cancer. In colorectal cancer patients, low ...
BCIQ Company Profiles
BCIQ Target Profiles